Ciglitazone(Synonyms: 环格列酮; ADD-3878; U-63287)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Ciglitazone (Synonyms: 环格列酮; ADD-3878; U-63287)

Ciglitazone 是一种有效的选择性 PPARγ 激动剂 (EC50=3 μM)。Ciglitazone 抑制 th17 细胞的增殖和分化。Ciglitazone 是一种口服降糖剂,在肥胖高血糖动物模型中具有活性。Ciglitazone 诱导负鼠肾上皮细胞凋亡 (apoptosis),同时激活 p38 MAPK 和凋亡诱导因子 (AIF) 的核转位。

Ciglitazone(Synonyms: 环格列酮; ADD-3878;  U-63287)

Ciglitazone Chemical Structure

CAS No. : 74772-77-3

规格 价格 是否有货 数量
5 mg ¥880 In-stock
10 mg   询价  
50 mg   询价  

* Please select Quantity before adding items.

生物活性

Ciglitazone is a potent and selective PPARγ agonist (EC50=3 μM). Ciglitazone inhibits proliferation and differentiation of th17 cells. Ciglitazone is a hypoglycemic agent orally active in the obese-hyperglycemic animal models. Ciglitazone induces apoptosis accompanied by activation of p38 MAPK and nuclear translocation of apoptosis inducing factor (AIF) in opossum kidney (OK) renal epithelial cells[1][2][3][4].

体外研究
(In Vitro)

Ciglitazone (0-20 μM; 24 hours) induces apoptosis through PPAR-independent mechanism. Ciglitazone causes generation of ROS and an increase in intracellular Ca2+[4].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

In C57BL/6J-ob/ob mice, Ciglitazone (100 mg/kg/day; 2 days) elicits a drastic fall in blood glucose. Regranulation of islet beta-cells and increased pancreatic insulin content are observed in ob/ob mice treated for 41-44 days with 100 mg/kg/day Ciglitazone[3].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

333.45

Formula

C18H23NO3S

CAS 号

74772-77-3

中文名称

环格列酮;酪里达唑

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献
  • [1]. Willson TM, et al. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem. 1996;39(3):665-668.

    [2]. Kim DH, et al. Ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, inhibits proliferation and differentiation of th17 cells. Biomol Ther (Seoul). 2015;23(1):71-76.

    [3]. Chang AY, et al. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats. Diabetes. 1983;32(9):830-838.

    [4]. Kwon CH, et al. Ciglitazone induces apoptosis via activation of p38 MAPK and AIF nuclear translocation mediated by reactive oxygen species and Ca(2+) in opossum kidney cells. Toxicology. 2009;257(1-2):1-9.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务